From Proteopedia
(Difference between revisions)
proteopedia linkproteopedia link
|
|
| Line 1: |
Line 1: |
| - | [[Image:2ov8.gif|left|200px]] | + | {{Seed}} |
| | + | [[Image:2ov8.png|left|200px]] |
| | | | |
| | <!-- | | <!-- |
| Line 9: |
Line 10: |
| | {{STRUCTURE_2ov8| PDB=2ov8 | SCENE= }} | | {{STRUCTURE_2ov8| PDB=2ov8 | SCENE= }} |
| | | | |
| - | '''Crystal Structure of StaL'''
| + | ===Crystal Structure of StaL=== |
| | | | |
| | | | |
| - | ==Overview==
| + | <!-- |
| - | Over the past decade, antimicrobial resistance has emerged as a major public health crisis. Glycopeptide antibiotics such as vancomycin and teicoplanin are clinically important for the treatment of Gram-positive bacterial infections. StaL is a 3'-phosphoadenosine 5'-phosphosulfate-dependent sulfotransferase capable of sulfating the cross-linked heptapeptide substrate both in vivo and in vitro, yielding the product A47934, a unique teicoplanin-class glycopeptide antibiotic. The sulfonation reaction catalyzed by StaL constitutes the final step in A47934 biosynthesis. Here we report the crystal structure of StaL and its complex with the cofactor product 3'-phosphoadenosine 5'-phosphate. This is only the second prokaryotic sulfotransferase to be structurally characterized. StaL belongs to the large sulfotransferase family and shows higher similarity to cytosolic sulfotransferases (ST) than to the bacterial ST (Stf0). StaL has a novel dimerization motif, different from any other STs that have been structurally characterized. We have also applied molecular modeling to investigate the binding mode of the unique substrate, desulfo-A47934. Based on the structural analysis and modeling results, a series of residues was mutated and kinetically characterized. In addition to the conserved residues (Lys(12), His(67), and Ser(98)), molecular modeling, fluorescence quenching experiments, and mutagenesis studies identified several other residues essential for substrate binding and/or activity, including Trp(34), His(43), Phe(77), Trp(132), and Glu(205).
| + | The line below this paragraph, {{ABSTRACT_PUBMED_17329243}}, adds the Publication Abstract to the page |
| | + | (as it appears on PubMed at http://www.pubmed.gov), where 17329243 is the PubMed ID number. |
| | + | --> |
| | + | {{ABSTRACT_PUBMED_17329243}} |
| | | | |
| | ==About this Structure== | | ==About this Structure== |
| Line 31: |
Line 35: |
| | [[Category: Structural genomic]] | | [[Category: Structural genomic]] |
| | [[Category: Sulfotransferase]] | | [[Category: Sulfotransferase]] |
| - | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Sun May 4 11:43:45 2008'' | + | |
| | + | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Mon Jul 28 08:54:54 2008'' |
Revision as of 05:55, 28 July 2008
Template:STRUCTURE 2ov8
Crystal Structure of StaL
Template:ABSTRACT PUBMED 17329243
About this Structure
2OV8 is a Single protein structure of sequence from Streptomyces toyocaensis. Full crystallographic information is available from OCA.
Reference
Crystal structure of StaL, a glycopeptide antibiotic sulfotransferase from Streptomyces toyocaensis., Shi R, Lamb SS, Bhat S, Sulea T, Wright GD, Matte A, Cygler M, J Biol Chem. 2007 Apr 27;282(17):13073-86. Epub 2007 Feb 28. PMID:17329243
Page seeded by OCA on Mon Jul 28 08:54:54 2008
